Supply chain digitalisation: don’t let the knock-on benefits pass you by
The move to digitalise supply chains is not a new development in the pharmaceutical industry. What has changed is the…
The move to digitalise supply chains is not a new development in the pharmaceutical industry. What has changed is the…
Global demand for drugs of all kinds is increasing. GlobalData’s drugs database forecasts global drug sales, from 2024 to 2030,…
In the wake of the Covid-19 vaccine, mRNA research and development increased dramatically. However, as the demand for Covid-19 vaccines…
The biomanufacturing sector is undergoing a revolution. Groundbreaking therapies are opening up new frontiers in the treatment of intractable ailments…
The landscape of genomic medicine is undergoing rapid transformation. According to a survey of hundreds of healthcare leaders conducted for…
The striking overlap between type 2 diabetes and obesity reflects the convergence in the underlying pathophysiology of these conditions –…
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…
A vast range of specialty commercial drug products require temperature-controlled distribution and storage to ensure quality, safety, and efficacy. Some of…
Biomanufacturing has had an interesting couple of years. Unprecedented spikes in demand from the global COVID-19 pandemic have been followed…
Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…